----
Current Valuation
-17.47xP/E
HK$35.50Stock price
HK$-2.03Earnings per share
-17.47xP/E
Stock priceHK$35.50Earnings per shareHK$-2.03
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
03876114152
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
06990HKSKB BIO | -232.91x | 49.28% | HK$98.50B |
09926HKAKESO | -65.41x | 103.74% | HK$80.60B |
02162HKKEYMED BIO-B | -31.49x | 194.20% | HK$18.22B |
07666HKMETIS TECHBIO-P | -40.43x | -- | HK$17.54B |
01877HKJUNSHI BIO | -23.97x | 34.28% | HK$17.01B |
09688HKZAI LAB | -11.57x | 45.18% | HK$16.15B |
09606HKDUALITYBIO-B | -5.47x | 86.82% | HK$15.72B |
06855HKASCENTAGE | -8.63x | 50.92% | HK$11.87B |
02627HKAB&B BIO-TECH-B | -46.87x | -- | HK$11.54B |
01779HKLONGBIO-B | -57.90x | -- | HK$11.26B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
